IMC-RON8 [33 (link)] and IMC-A12 [34 (link)] monoclonal antibodies were provided by ImClone Systems Corporation (Branchburg, NJ, USA) through a Material Transfer Agreement. Recombinant human MSP (Cat-No. 352-MS) was from R&D Systems (Minneapolis, MN, USA) and recombinant human insulin-like growth factor 1 (IGF1; Cat-No. I3769) and 5-Aza-2’-deoxycytidine (5-Aza-CdR, Decitabine; Cat-No. A3656) were from Sigma-Aldrich (St. Louis, MO, USA).
Free full text: Click here
